Does PAZOPANIB Cause Therapy non-responder? 42 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Therapy non-responder have been filed in association with PAZOPANIB (Pazopanib). This represents 0.2% of all adverse event reports for PAZOPANIB.
42
Reports of Therapy non-responder with PAZOPANIB
0.2%
of all PAZOPANIB reports
6
Deaths
6
Hospitalizations
How Dangerous Is Therapy non-responder From PAZOPANIB?
Of the 42 reports, 6 (14.3%) resulted in death, 6 (14.3%) required hospitalization, and 4 (9.5%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PAZOPANIB. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does PAZOPANIB Cause?
Death (3,767)
Diarrhoea (2,907)
Fatigue (1,883)
Nausea (1,879)
Malignant neoplasm progression (1,471)
Drug ineffective (1,135)
Decreased appetite (1,116)
Vomiting (1,072)
Hypertension (1,004)
Malaise (764)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which PAZOPANIB Alternatives Have Lower Therapy non-responder Risk?
PAZOPANIB vs PEANUT
PAZOPANIB vs PEG INTERFERON
PAZOPANIB vs PEG-INTERFERON ALFA 2A
PAZOPANIB vs PEGASPARGASE
PAZOPANIB vs PEGASYS